---
{"dg-publish":true,"dg-path":"Rad/MSK/Bone/Bony lesions/Lytic lesions/Malignant/Chondrosarcoma.md","permalink":"/rad/msk/bone/bony-lesions/lytic-lesions/malignant/chondrosarcoma/"}
---

## Overview
- **Malignant cartilage-producing tumor**
- **Second most common primary malignant bone tumor in adults** (after [[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Malignant/Multiple myeloma\|myeloma]])
- Can be **primary** or **secondary** from [[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Benign/Osteochondroma\|Osteochondroma]] or [[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Benign/Enchondroma\|Enchondroma]]
## Epidemiology
- Age: Typically **>40 years**
- Male predominance
- Secondary types often occur in younger adults with **[[30_Rad Knowledge/MSK/Bone/Multiple lesions conditions/Multiple hereditary exostoses\|multiple hereditary exostoses]]** or **[[enchondromatosis\|enchondromatosis]]**
## Locations
- **Pelvis**, **proximal femur**, **scapula**, **ribs**
- Long bones: metaphyseal-diaphyseal regions
- Can occur in flat bones and small bones (hands/feet in Maffucci)
## Histology
- Lobules of **hyaline cartilage** with variable cellularity
- Binucleated chondrocytes may be present
- Grading (1–3) based on mitotic activity, cellularity, nuclear atypia
## Subtypes

| Subtype              | Notes                                                                                        |
| -------------------- | -------------------------------------------------------------------------------------------- |
| **Conventional**     | Most common                                                                                  |
| **Clear cell**       | Epiphyseal, younger adults, low-grade                                                        |
| **Dedifferentiated** | High-grade, aggressive                                                                       |
| **Mesenchymal**      | Rare, [[30_Rad Knowledge/MSK/Soft tissue/Soft tissue tumor/Sarcoma/Small round blue cell tumours\|small round cell]] component                                    |
| **Secondary**        | From [[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Benign/Osteochondroma\|Osteochondroma]] or [[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Benign/Enchondroma\|Enchondroma]]; transformation risk increases with size and pain |


---
## Imaging Features
### X-ray / CT
- **Lytic lesion with chondroid matrix**:
  - **Rings and arcs**
  - **Stippled** or **flocculent** calcification
- Endosteal scalloping (especially in long-standing enchondroma)
- Cortical destruction or soft tissue mass suggests malignancy
- **>2 cm cartilage cap** in osteochondroma = suspicious for secondary transformation
### MRI
- T1: Low to intermediate signal
- T2: Very **high signal** (cartilage is water-rich)
- Post-contrast: Heterogeneous enhancement; helps define extent and soft tissue involvement
- Look for:
  - Endosteal scalloping > 2/3 cortex
  - Cortical breach or soft tissue mass
  - Intramedullary size >5 cm favors malignancy
---
## Differential Diagnosis

| Diagnosis                                      | Key Differences                                   |
| ---------------------------------------------- | ------------------------------------------------- |
| **[[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Benign/Enchondroma\|Enchondroma]]**                            | Smaller, asymptomatic, no cortical breach or mass |
| **[[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Benign/Osteochondroma\|Osteochondroma]]**                         | Benign if cartilage cap < 1.5–2 cm (adults)       |
| **[[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Benign/Fibrous dysplasia\|Fibrous dysplasia]]**                      | Ground-glass matrix, no cartilage calcification   |
| **Low-grade [[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Malignant/Osteosarcoma\|Osteosarcoma]]**                 | Osteoid matrix, more periosteal reaction          |
| **Metastasis / [[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Malignant/Multiple myeloma\|Myeloma]]** | No chondroid matrix; age-dependent                |
## Management
- **Surgical resection with wide margins** is mainstay
- **Chemotherapy and radiotherapy are generally ineffective** (except mesenchymal subtype)
## Prognosis
- Depends on **grade**, **location**, and **subtype**
- Low-grade: Good prognosis with adequate resection
- High-grade: Risk of recurrence and metastasis
- Dedifferentiated and mesenchymal: Poorer prognosis
---
## Exam tips
- Middle-aged patient + **pelvic/long bone lytic lesion** + **rings and arcs** = chondrosarcoma
- Key differentiator from [[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Benign/Enchondroma\|Enchondroma]]:
	- **Pain**, **soft tissue mass**, **cortical destruction**, or **cap >2 cm**
- Watch out for **secondary transformation** in known [[30_Rad Knowledge/MSK/Bone/Bony lesions/Lytic lesions/Benign/Osteochondroma\|Osteochondroma]]
## Real-Life Reporting Tips
- Report:
	- **Matrix type** (chondroid vs osteoid)
	- **Presence/absence of soft tissue mass**
	- **Cortical breakthrough or endosteal scalloping**
	- **Cap thickness** (if osteochondroma)
- Suggest malignancy if:
	- Lesion is **painful**, enlarging
	- Intramedullary size **>5 cm**, aggressive features
	- Cartilage cap **>2 cm** in adults